Novartis的例句大全

Novartis is further evaluating Femara compared to tamoxifen in the adjuvant setting.

弗隆用作辅助药时,诺华以他莫昔芬为对照,对它做了进一步的评估.

Novartis said that itis seeking to acquire OTC drug firms in China.

诺华宣称他们正积极在华寻找非处方药厂.

In the pharmaceuticals sector alone, Roche, Novartis and GlaxoSmithKline have all established laboratories in Shanghai.

仅在制药业, 罗氏(Roche) 、 诺华(Novartis)和葛兰素史克(GlaxoSmithKline)等公司均在上海建立了实验室.

Novartis has an approved cell culture vaccine in Europe.

诺华细胞培养疫苗在欧洲已获许可.

Novartis set up its Shanghai research facilities in 2006 a $ 100 m investment.

诺华制药于2006年投资1亿美元在上海建立了研发中心,重点研究导致癌症的感染因素.

And Novartis will offer Alcon greater opportunities to develop new medical technologies than Nestl é.

诺华制药可以比雀巢给爱尔康带来更好的发展新药科技的机遇.

Voltaren Gel was shown to cut pain in knee and hand osteoarthritis, states Novartis.

研究结果显示，扶他林乳胶剂对膝盖和手性关节疼痛有阻断作用。

But Novartis has decided re-think the methodology behind drug development, Jimenez says.

而江慕忠表示，诺华公司决定重新考虑药物开发方案。

Paul Herrling of Novartis points out that virally induced cancers are rare in Europe but common in China.

诺华制药的保尔·哈林指出，由滤过性毒菌导致的癌症在欧洲很少出现，但在中国是很普遍的疾病。

High costs are viewed as one of the biggest drawbacks of the so-called CAR-T therapies under development by Novartis, Juno and Kite.

诺华制药、Juno和Kite正在研制中的所谓CAR-T疗法的最大缺点之一，就是被认为价格太高。

Novartis ( NVS) has a new strategy to try to generate that kind of serendipity.

诺华公司新策略的目的就是找到这种意外的惊喜。

Proof-of-concept data are expected soon on a second Novartis compound, known as KAF 156.

预计诺华的第二种复方药物（名为KAF156）的概念验证数据将很快出炉。

Several big foreign drugmakers have opened research and development centres in China, or are planning to do so – including Novartis, Pfizer and Johnson Johnson.

多家大型外资制药商在中国开设了研发中心，或是有这样做的计划，其中包括诺华（Novartis）、辉瑞（Pfizer）和强生（Johnson Johnson）。

The French government has bought 94 million doses of "swine flu" vaccine from Baxter, GSK, Novartis and Sanofi to carry out the forced vaccination programme.

法国政府已经从巴克斯特公司、葛兰素史克公司、诺华公司和赛诺菲公荀购买了9400万剂疫苗进行强制免疫计划。

Those strains are then produced and handed off to manufacturers, such as GlaxoSmithKline, Novartis and Sanofi, to produce and distribute-a process that requires significant lead time to ensure the doses reach doctor offices by early October.

这些病毒株会被大量生产，然后交给葛兰素史克、诺华和赛诺菲等生产厂家来生产和销售——这个过程需要显著的提前期，才能保证疫苗在10月初到达各地的医院。

The leading flu-vaccine manufacturers include Sanofi and Novartis.

领先的流感疫苗生产商包括赛诺菲和诺华。